Aldesleukin
| Aldesleukin | |
|---|---|
| Term | Aldesleukin |
| Short definition | aldesleukin (AL-of-LOO-kin) drug used to treat adults with melanoma or renal cell carcinoma (a type of kidney cancer) that has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
aldesleukin - (pronounced) (AL-of-LOO-kin) drug used to treat adults with melanoma or renal cell carcinoma (a type of kidney cancer) that has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Aldesleukin is a laboratory-made form of interleukin-2. Aldesleukin increases the activity and growth of white blood cells called T lymphocytes and B lymphocytes, which can help the immune system kill cancer cells. Aldesleukin is a type of cytokine and a type of immunomodulating agent. Also called proleukin and recombinant human interleukin-2
External links
- Medical encyclopedia article on Aldesleukin
- Wikipedia's article - Aldesleukin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski